Top Articles - Finance

In the news recently, I’ve come across a lot of information regarding debt collection agencies and their practice

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

of collecting money from years-old debt. For those in the know, this debt is often referred to as “zombie debt”

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ince, quite accurately, it seems to have come back from the dead.

A friend of mine recently received a call from

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

a collection agency regarding a debt from over a decade ago (and on top of that, he knows for a fact that this bi

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

l was paid). He took down the information and gave me a call. I told him that debt collectors cheaply buy old deb

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s from companies. And, as per usual, they’re aggressive and unceasing in trying to make you pay for old debt.

A

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

uick online search regarding this issue turned up too many results, which only underscores how big of a problem t

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

his is. Debt collectors will sometimes go after these zombie debts–even if they have been paid. For those of you

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ith credit histories that are squeaky clean–just as my friend’s credit history is–continue to be aware of this is

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ue. In his case, the financial record was lost and he almost paid the bill thinking it would be the easiest optio

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

.

If you find that you’re being pestered by a deb collector for an old debt, then know your rights.
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
ng>

You should also contact your state attorney general’s office to find out the statute of limitations on years
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
old debts. You should be aware that there different rules apply not only in different states but also in dealing
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ith the statutes for different types of debts (health care debts may have a different statute of limitation then
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
a credit card debt, for example). Even if the debt is outstanding, if it falls beyond the limits of the statutes,
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
then you are not required to repay it. (I suggest that you speak to a financial professional once you have all th
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
information you need, though.)

Furthermore, many financial professionals suggest that, if you are contacted by
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
he collection agency for a zombie debt, you should send them a certified letter with a return receipt asking for
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
he details of the debt they are trying to collect.

As always, know your rights and do your research. If you are
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
onfused about an issue, you should always talk to your own financial advisor so you can make an informed decision

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Top Articles - Debt Collectors & Zombie Debts: Be Informed

Related Articles: